Ignite Creation Date:
2024-05-05 @ 5:18 PM
Last Modification Date:
2024-10-26 @ 9:30 AM
Study NCT ID:
NCT00424606
Status:
COMPLETED
Last Update Posted:
2015-05-20
First Post:
2007-01-18
Brief Title:
Epirubicin and Docetaxel Combination ET or Epirubicin Followed by Docetaxel ET for Node Negative N0 High Risk Breast Cancer Patients
Sponsor:
Hellenic Oncology Research Group
Organization:
Hellenic Oncology Research Group
Conditions & Keywords Data
Conditions:
| Name |
|---|
| Breast Cancer |
Keywords:
| Name | View |
|---|---|
| High risk node negative | View |